Abstract
Introduction
Type 2 diabetes mellitus (DM) is associated with hyperinsulinemia, which may lead to increased risk of carcinogenesis by increasing insulin-like growth factor-1 level. In this study, we sought to determine the association between type 2 DM and colon adenomas.
Methods
In this retrospective case–control study, all the colonoscopies performed in an urban medical center during a 3-year period were reviewed. Patients with adenomatous polyps were considered as cases (n = 261). Age- and sex-matched controls with a 2:1 ratio were selected (n = 522). Among diabetic subjects, the association of different anti-diabetic medications and HbA1C level with high-risk adenoma features was analyzed.
Results
Type 2 DM was significantly associated with colon adenomas (odds ratio (OR) = 1.45, 95% confidence interval (CI) = 1.05–2.01, p = 0.024). Exposure to insulin (OR = 1.734, 95% CI = 1.13–2.65, p = 0.013) and thiazolidinediones (OR = 2.83, 95% CI = 1.28–6.26, p = 0.01) was associated with developing adenomas. Neither the type of antidiabetic medication nor the level of HbA1C was a predictor for high-risk adenomas. Smoking (OR = 1.47, 95% CI = 1.07–2.02, p = 0.02), use of aspirin (OR = 1.59, 95% CI = 1.15–2.20, p = 0.005), and statins (OR = 1.54, 95% CI = 1.13–2.10, p = 0.007) appeared to increase the risk of adenomas.
Conclusion
This study shows a significant association between type 2 DM and colon adenomas. Establishing this association may lead to inclusion of diabetic patients in the high-risk group for developing colorectal cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
Winawer SJ, Zauber AG, Gerdes H, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–81.
Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer. 2004;108:433–42.
Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166:1871–7.
Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:1679–87.
Ma J, Pollak MN, Giovannucci E, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999;91:620–5.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1):S62–9.
Pezzullo JC. Logistic regression. 2008. Available from http://www.statpages.org/logistic.html. Accessed 2 Mar 2011.
Jayatilaka S, Shakov R, Eddi R, Bakaj G, Baddoura WJ, Debari VA. Clostridium difficile infection in an urban medical center: 5-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors. Ann Clin Lab Sci. 2007;37:241–7.
Grote VA, Becker S, Kaaks R. Diabetes mellitus type 2—an independent risk factor for cancer? Exp Clin Endocrinol Diabetes. 2010;118:4–8.
Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001;131(11 Suppl):3109S–20S.
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.
Takayama T, Katsuki S, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339:1277–84.
Yoshida I, Suzuki A, et al. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon. Clin Gastroenterol Hepatol. 2006;4:1225–31.
Kono S, Honjo S, et al. Glucose intolerance and adenomas of the sigmoid colon in Japanese men. Cancer Causes Control. 1998;9:441–6.
Lee GE, Park HS, et al. Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity. 2008;16:1434–9.
Kim JH, Lim YJ, et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev. 2007;16:1543–6.
Siddiqui A, Maddur H, et al. The association of elevated HbA1C on the behavior of adenomatous polyps in patients with type-II diabetes mellitus. Dig Dis Sci. 2008;53:1042–7.
Lin MS, Chen WC, Bai X, Wang YD. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. J Dig Dis. 2007;8:82–8.
Govindarajan R, Ratnasinghe L, et al. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol. 2007;25:1476–81.
Rostom A, Dub C, Lewin G, et al. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med. 2007;146:376–89.
Dale KM, Coleman CI, et al. Statins and cancer risk: a meta-analysis. JAMA. 2006;295:74–80.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eddi, R., Karki, A., Shah, A. et al. Association of Type 2 Diabetes and Colon Adenomas. J Gastrointest Canc 43, 87–92 (2012). https://doi.org/10.1007/s12029-011-9316-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-011-9316-7